Rapid approval of drugs eyed

Published: 2011-02-21 06:59:00

Updated: 2011-02-21 06:59:00

The Korea Food and Drug Administration said Thursday that it will revise the screening procedures for new rules as part of its efforts to provide better support for the domestic drug makers to develop specific drugs, such rare drug, children drugs and anti-cancers.

The KFDA also said it will p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK